BMedical - DevicesButterfly Network, Inc. (BFLY)
0.1%
Avg. buy price
$8.74
Estimated gain−77.1%Quarter-end price
$2.00
Last transaction
Reduced· Q2 2025Sold 8.7% of shares
Cathie Wood founded ARK Investment Management and serves as its chief executive and chief investment officer.
ARK Investment Management LLC Holdings · Q2 2025
Estimated gain compares the quarter-end mark with a running share-weighted mean of covered-snapshot and add-quarter mean prices. Holdings with incomplete basis or price coverage are excluded.
| Stock | % | Avg. buy price | Estimated gain | Quarter-end price | Last transaction | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
BMedical - DevicesButterfly Network, Inc. (BFLY)
0.1%
Avg. buy price
$8.74
Estimated gain−77.1%Quarter-end price
$2.00
Last transaction
Reduced· Q2 2025Sold 8.7% of shares
|
B
Medical - DevicesButterfly Network, Inc. (BFLY)
|
0.1% | $8.74 | −77.1% | $2.00 | Reduced· Q2 2025Sold 8.7% of shares | |||||
 REntertainmentRoku, Inc. (ROKU)
5.5%
Avg. buy price
$192.33
Estimated gain−54.3%Quarter-end price
$87.89
Last transaction
Reduced· Q2 2025Sold 2.1% of shares
|
R
EntertainmentRoku, Inc. (ROKU)
|
5.5% | $192.33 | −54.3% | $87.89 | Reduced· Q2 2025Sold 2.1% of shares | |||||
 EMedical - Diagnostics & ResearchExact Sciences Corporation (EXAS)
0.0%
Avg. buy price
$108.44
Estimated gain−51.0%Quarter-end price
$53.14
Last transaction
Reduced· Q1 2025Sold 100.0% of shares
|
E
Medical - Diagnostics & ResearchExact Sciences Corporation (EXAS)
|
0.0% | $108.44 | −51.0% | $53.14 | Reduced· Q1 2025Sold 100.0% of shares | |||||
 USoftware - ApplicationUnity Software Inc. (U)
0.2%
Avg. buy price
$47.70
Estimated gain−49.3%Quarter-end price
$24.20
Last transaction
Added· Q2 2025Increased shares by 0.9%
|
U
Software - ApplicationUnity Software Inc. (U)
|
0.2% | $47.70 | −49.3% | $24.20 | Added· Q2 2025Increased shares by 0.9% | |||||
 VBiotechnologyVeracyte, Inc. (VCYT)
0.8%
Avg. buy price
$51.74
Estimated gain−47.8%Quarter-end price
$27.03
Last transaction
Reduced· Q2 2025Sold 3.5% of shares
|
V
BiotechnologyVeracyte, Inc. (VCYT)
|
0.8% | $51.74 | −47.8% | $27.03 | Reduced· Q2 2025Sold 3.5% of shares | |||||
 RBiotechnologyRecursion Pharmaceuticals, Inc. (RXRX)
1.2%
Avg. buy price
$8.31
Estimated gain−39.1%Quarter-end price
$5.06
Last transaction
Reduced· Q2 2025Sold 5.2% of shares
|
R
BiotechnologyRecursion Pharmaceuticals, Inc. (RXRX)
|
1.2% | $8.31 | −39.1% | $5.06 | Reduced· Q2 2025Sold 5.2% of shares | |||||
 UIntegrated Freight & LogisticsUnited Parcel Service, Inc. (UPS)
0.0%
Avg. buy price
$157.98
Estimated gain−36.1%Quarter-end price
$100.94
Last transaction
Added· Q2 2025Increased shares by 6.4%
|
U
Integrated Freight & LogisticsUnited Parcel Service, Inc. (UPS)
|
0.0% | $157.98 | −36.1% | $100.94 | Added· Q2 2025Increased shares by 6.4% | |||||
 BSoftware - ApplicationBill.com Holdings, Inc. (BILL)
0.1%
Avg. buy price
$67.25
Estimated gain−31.2%Quarter-end price
$46.26
Last transaction
Reduced· Q2 2025Sold 7.9% of shares
|
B
Software - ApplicationBill.com Holdings, Inc. (BILL)
|
0.1% | $67.25 | −31.2% | $46.26 | Reduced· Q2 2025Sold 7.9% of shares | |||||
 EChemicals - SpecialtyEastman Chemical Company (EMN)
0.0%
Avg. buy price
$103.65
Estimated gain−28.0%Quarter-end price
$74.66
Last transaction
Added· Q2 2025Increased shares by 3.8%
|
E
Chemicals - SpecialtyEastman Chemical Company (EMN)
|
0.0% | $103.65 | −28.0% | $74.66 | Added· Q2 2025Increased shares by 3.8% | |||||
 PMedical - DevicesPacific Biosciences of California, Inc. (PACB)
0.3%
Avg. buy price
$1.66
Estimated gain−25.5%Quarter-end price
$1.24
Last transaction
Reduced· Q2 2025Sold 0.5% of shares
|
P
Medical - DevicesPacific Biosciences of California, Inc. (PACB)
|
0.3% | $1.66 | −25.5% | $1.24 | Reduced· Q2 2025Sold 0.5% of shares | |||||
 TMedical - Healthcare Information Services10x Genomics, Inc. (TXG)
1.2%
Avg. buy price
$15.07
Estimated gain−23.2%Quarter-end price
$11.58
Last transaction
Added· Q2 2025Increased shares by 8.1%
|
T
Medical - Healthcare Information Services10x Genomics, Inc. (TXG)
|
1.2% | $15.07 | −23.2% | $11.58 | Added· Q2 2025Increased shares by 8.1% | |||||
 TAdvertising AgenciesThe Trade Desk, Inc. (TTD)
0.8%
Avg. buy price
$90.47
Estimated gain−20.4%Quarter-end price
$71.99
Last transaction
Reduced· Q2 2025Sold 5.4% of shares
|
T
Advertising AgenciesThe Trade Desk, Inc. (TTD)
|
0.8% | $90.47 | −20.4% | $71.99 | Reduced· Q2 2025Sold 5.4% of shares | |||||
 LAerospace & DefenseIntuitive Machines, Inc. (LUNR)
0.1%
Avg. buy price
$13.59
Estimated gain−20.0%Quarter-end price
$10.87
Last transaction
Added· Q2 2025Increased shares by 56.1%
|
L
Aerospace & DefenseIntuitive Machines, Inc. (LUNR)
|
0.1% | $13.59 | −20.0% | $10.87 | Added· Q2 2025Increased shares by 56.1% | |||||
 AMedical - DevicesAlign Technology, Inc. (ALGN)
0.0%
Avg. buy price
$235.14
Estimated gain−19.5%Quarter-end price
$189.33
Last transaction
Added· Q2 2025Increased shares by 3.7%
|
A
Medical - DevicesAlign Technology, Inc. (ALGN)
|
0.0% | $235.14 | −19.5% | $189.33 | Added· Q2 2025Increased shares by 3.7% | |||||
 IBiotechnologyIonis Pharmaceuticals, Inc. (IONS)
0.3%
Avg. buy price
$48.72
Estimated gain−18.9%Quarter-end price
$39.51
Last transaction
Reduced· Q2 2025Sold 10.0% of shares
|
I
BiotechnologyIonis Pharmaceuticals, Inc. (IONS)
|
0.3% | $48.72 | −18.9% | $39.51 | Reduced· Q2 2025Sold 10.0% of shares | |||||
P
Palantir Technologies Inc. (PLTR)
−$259M
R
Roblox Corporation (RBLX)
−$181M
H
Robinhood Markets, Inc. (HOOD)
−$146M
C
Coinbase Global, Inc. (COIN)
−$104M
P
UiPath Inc. (PATH)
Exited−$100M
M
Meta Platforms, Inc. (META)
−$78M
T
Tesla, Inc. (TSLA)
−$55M
C
CoreWeave, Inc. Class A Common Stock (CRWV)
−$17M
C
Circle Internet Group (CRCL)
New+$455M
A
Advanced Micro Devices, Inc. (AMD)
+$140M
A
Airbnb, Inc. (ABNB)
+$91M
T
Taiwan Semiconductor Manufacturing Company Limited (TSM)
+$88M
N
NVIDIA Corporation (NVDA)
+$83M
G
Guardant Health, Inc. (GH)
+$63M
B
BWX Technologies, Inc. (BWXT)
+$61M
S
Shopify Inc. (SHOP)
+$61M
A
Adaptive Biotechnologies Corporation (ADPT)
−3.7M
D
3D Systems Corporation (DDD)
−2.8M
C
Cerus Corporation (CERS)
−1.4M
R
Repare Therapeutics Inc. (RPTX)
Exited−1.1M
A
AvidXchange Holdings, Inc. (AVDX)
Exited−943K
A
Absci Corporation (ABSI)
−909K
P
Prime Medicine, Inc. (PRME)
−773K
G
GitLab Inc. (GTLB)
+866K
B
Beam Therapeutics Inc. (BEAM)
+368K
N
Nano Dimension Ltd. (NNDM)
+339K
I
Illumina, Inc. (ILMN)
+273K
Largest holdings in Q2 2025, sized by their share of the disclosed portfolio. This shows what is owned, not what changed.
R
Roku, Inc. (ROKU)
5.5%
Cathie Wood founded ARK Investment Management and serves as its chief executive and chief investment officer. This page shows ARK Investment Management's quarterly Form 13F report of certain United States listed long positions, not Wood's personal account or every ARK fund. Cash, short positions, private investments, many derivatives, and daily fund trades are outside this view.
Profile refreshed July 20, 2026
As of the Q2 2025 filing, Cathie Wood's largest disclosed holdings are Tesla, Inc. (TSLA), Coinbase Global, Inc. (COIN), Roku, Inc. (ROKU). The table shows 15 of 191 positions by default, with an exact-count control for the remaining rows. Disclosed shares and values remain visible even when a separate market-price estimate is unavailable.
The biggest disclosed buys in Q2 2025 were Circle Internet Group (CRCL), Advanced Micro Devices, Inc. (AMD), Airbnb, Inc. (ABNB), based on the ARK Investment Management LLC 13F filing. New positions are marked "new" in the table above.
The biggest reductions in Q2 2025 were Palantir Technologies Inc. (PLTR), Roblox Corporation (RBLX), Robinhood Markets, Inc. (HOOD). The filing comparison contains 6 full exits, summarized in the activity view above.
The latest 13F discloses $13.6B across 191 positions in Q2 2025. 13F filings cover US-listed long positions only; cash and short positions are not disclosed.
Funds file 13Fs up to 45 days after each quarter ends, so this portfolio reflects Q2 2025, the latest disclosed quarter. The filing date is shown with every table.
Non-rejected, non-superseded SEC Form 13F filings for ARK Investment Management LLC provide the Q2 2025 holdings, disclosed values, and filing date shown here. WhoBought prefers filings whose value units validate and labels a sparse filing when validation is unavailable. Industry labels come from the local company classification record.
Performance uses daily closing prices for holdings with available market-price history. It covers the priced share of disclosed value (77%); holdings without sufficient price history are excluded from the calculation.
Cathie Wood is an American investor who co-founded ARK Invest and serves as its chief executive. On this page, ARK's filed portfolio is the relevant data source, not Wood's personal account.
Her career included roles at Capital Group, Jennison Associates, Tupelo Capital Management, and AllianceBernstein, where she led global thematic strategies.
She left AllianceBernstein after her proposal for actively managed ETFs centered on disruptive innovation was judged too risky. She founded ARK in 2014 to pursue that idea.
ARK's approach centers on companies it believes are driving disruptive innovation. Its funds are actively managed rather than simply following a broad market index.
Yes. She remains ARK's chief executive and chief investment officer.
It has been highly uneven. ARK Innovation had exceptional results in 2020, fell 24 percent in 2021, substantially underperformed the Nasdaq-100 through 2023, and rebounded strongly in 2025.
No. It is ARK Investment Management's 13F filing. It does not show Wood's personal account, every ARK fund, or all of ARK's assets.
No. The page uses quarterly 13F filings, while ARK funds can trade between reporting dates. Use the holdings and change tables to study the filed quarter-end portfolio, not as a record of every daily transaction.
